Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicure Inc
V.MPH
Alternate Symbol(s):
MCUJF
Healthcare
Biotechnology
Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company...
's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(9)
•••
pholover
X
Comment by
pholover
on Oct 22, 2024 1:45pm
RE:Oct 23 will be 6 months from fast track date
The share price to me, appears to be reflecting people figuring out, looking at their cash flow statement that they have not made their proper payments to Zydus for Zipitimag and are in danger of
...more
(3)
•••
Checkout
X
Post by
Checkout
on Oct 03, 2024 10:33am
Oct 23 will be 6 months from fast track date
of April 23. This is the timeline to have it finished and the potential of a 100 - 200 million pay check. Place your bets. The drug works, but maybe too well because if the children do not take it....
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(9)
•••
pholover
X
Comment by
pholover
on Sep 22, 2024 12:33am
RE:RE:Will this be just another Bert Friesen Failure?
Very insightful post Whalewatcher. I have heard that it has been brought to the attention of more than one Director. Self dealing/filing patents using a related Company in this case is
...more
(3)
•••
Checkout
X
Post by
Checkout
on Sep 20, 2024 1:33pm
forgive my math
if MC1 is approved, and we sell the voucher from FDA for at least $100,000,000 with 10,000,000 shares outstanding, on paper, would that not be a ten bagger of the current share price of 1$ We have no
...more
(3)
•••
Checkout
X
Comment by
Checkout
on Sep 18, 2024 2:31pm
RE:RE:April May and June gone
it fast tracked is within 6 months would it not seem silly to be labeled fast tracked and then get delayed. Odds are in our favor. Problem: Pyridox (am) ine 5'-phosphate oxidase (PNPO
...more
(3)
•••
Checkout
X
Comment by
Checkout
on Sep 18, 2024 2:23pm
RE:April May and June gone
July, Aug, Sept we are getting close to a decision from FDA.
(3)
•••
Checkout
X
Post by
Checkout
on Sep 10, 2024 11:03am
Hopefully Friesens work will soon lead to $150,000,000 US
in his and his companies pocket.
(2)
•••
Whalewatcher1
X
Comment by
Whalewatcher1
on Sep 09, 2024 10:44pm
RE:Will this be just another Bert Friesen Failure?
Hey Pholover, How does this board allow Bert to continue his self serving? Bert’s Medicure MC-1 fails, so he uses one of his personally owned holding company to file patents on next
...more
(9)
•••
pholover
X
Post by
pholover
on Aug 07, 2024 11:30pm
Will this be just another Bert Friesen Failure?
His original idea with this drug for Heart Surgery just did not last long enough in the bloodstream to work. It is not likely he will fail here too? ..His whole career has been stuff that has not
...more
(3)
•••
Checkout
X
Post by
Checkout
on Jul 10, 2024 6:02pm
April May and June gone
Review Timelines: Under standard review, the FDA typically reviews a drug application in approximately ten months. With Priority Review, the FDA completes the review within six months
(3)
•••
Checkout
X
Comment by
Checkout
on Jul 10, 2024 5:31pm
RE:According to case reports, treatment with PLP can prevent
if we get FDA approval we also recieve a fast track voucher worth 100 - 200 million dollars. The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results
...more
(3)
•••
Checkout
X
Post by
Checkout
on Jul 10, 2024 5:28pm
According to case reports, treatment with PLP can prevent
2) May Be Better for Some Forms of Vitamin B6-Dependent Seizures The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results in seizures, known as vitamin
...more
(2)
•••
Whalewatcher1
X
Comment by
Whalewatcher1
on Jun 28, 2024 10:25am
RE:New Press Release - Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
When will these selft dealings end. Go look back at the last 30 years and its just one self-dealing after the other. Bert's gotten rich, while there isnt a single company that investors did well
...more
(2)
•••
Whalewatcher1
X
Comment by
Whalewatcher1
on Jun 28, 2024 10:22am
RE:we are led by greatness
HaHa! This and other awards are all paid. For like $10k these magazines will profile you. Only those with MASSIVE ego's would pay. Go to their website and look at the list of paid awards . .
...more
(9)
•••
pholover
X
Comment by
pholover
on Jun 24, 2024 8:55pm
RE:Someone tell me the odds are not in our favor.
This "worries" me that Friesen is taking more money from MPH to his Company. This guy strips all the cash and then if things work out, great if not, he still gets hundreds of thousands
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities